132 related articles for article (PubMed ID: 35657662)
1. Expression profiles of the genes associated with zinc homeostasis in normal and cancerous breast and prostate cells.
Barman SK; Zaman MS; Veljanoski F; Malladi CS; Mahns DA; Wu MJ
Metallomics; 2022 Aug; 14(8):. PubMed ID: 35657662
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic insights into the zinc homeostasis of MCF-7 breast cancer cells via next-generation RNA sequencing.
Zaman MS; Barman SK; Corley SM; Wilkins MR; Malladi CS; Wu MJ
Metallomics; 2021 Jun; 13(6):. PubMed ID: 33960390
[TBL] [Abstract][Full Text] [Related]
3. Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study.
Lin SF; Wei H; Maeder D; Franklin RB; Feng P
J Nutr Biochem; 2009 Dec; 20(12):1000-12. PubMed ID: 19071009
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.
Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P
Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603
[TBL] [Abstract][Full Text] [Related]
5. Stage-specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis.
Prasad RR; Raina K; Mishra N; Tomar MS; Kumar R; Palmer AE; Maroni P; Agarwal R
Mol Carcinog; 2022 May; 61(5):454-471. PubMed ID: 35049094
[TBL] [Abstract][Full Text] [Related]
6. Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc.
Barman SK; Sen MK; Mahns DA; Wu MJ; Malladi CS
J Oncol; 2024; 2024():9925970. PubMed ID: 38249992
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase CK2 is involved in zinc homeostasis in breast and prostate cancer cells.
Zaman MS; Johnson AJ; Petersingham G; Muench GW; Dong Q; Wu MJ
Biometals; 2019 Dec; 32(6):861-873. PubMed ID: 31583500
[TBL] [Abstract][Full Text] [Related]
8. Influence of DNA-methylation on zinc homeostasis in myeloid cells: Regulation of zinc transporters and zinc binding proteins.
Kessels JE; Wessels I; Haase H; Rink L; Uciechowski P
J Trace Elem Med Biol; 2016 Sep; 37():125-133. PubMed ID: 26905204
[TBL] [Abstract][Full Text] [Related]
9. Regulation of zinc homeostasis by inducible NO synthase-derived NO: nuclear metallothionein translocation and intranuclear Zn2+ release.
Spahl DU; Berendji-Grün D; Suschek CV; Kolb-Bachofen V; Kröncke KD
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13952-7. PubMed ID: 14617770
[TBL] [Abstract][Full Text] [Related]
10. Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.
Yin H; Smith M; Glass J
Prostate; 2005 Feb; 62(3):209-16. PubMed ID: 15389791
[TBL] [Abstract][Full Text] [Related]
11. Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma.
Gumulec J; Masarik M; Krizkova S; Adam V; Hubalek J; Hrabeta J; Eckschlager T; Stiborova M; Kizek R
Curr Med Chem; 2011; 18(33):5041-51. PubMed ID: 22050752
[TBL] [Abstract][Full Text] [Related]
12. Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells.
Wong PF; Abubakar S
Oncol Rep; 2010 Jun; 23(6):1501-16. PubMed ID: 20428803
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC
J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and reliability of zinc transporter and metallothionein gene expression in peripheral blood mononuclear cells as indicators of zinc status: responses to
Hennigar SR; Kelley AM; Anderson BJ; Armstrong NJ; McClung HL; Berryman CE; Karl JP; McClung JP
Br J Nutr; 2021 Feb; 125(4):361-368. PubMed ID: 32698913
[TBL] [Abstract][Full Text] [Related]
15. Zinc dysregulation in cancers and its potential as a therapeutic target.
Wang J; Zhao H; Xu Z; Cheng X
Cancer Biol Med; 2020 Aug; 17(3):612-625. PubMed ID: 32944394
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein expression in human prostate gland.
Bataineh ZM; Nusier MK
Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
[TBL] [Abstract][Full Text] [Related]
18. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
[TBL] [Abstract][Full Text] [Related]
19. Expression of Metallothionein and Vascular Endothelial Growth Factor Isoforms in Breast Cancer Cells.
Wierzowiecka B; Gomulkiewicz A; Cwynar-Zajac L; Olbromski M; Grzegrzolka J; Kobierzycki C; Podhorska-Okolow M; Dziegiel P
In Vivo; 2016; 30(3):271-8. PubMed ID: 27107086
[TBL] [Abstract][Full Text] [Related]
20. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues.
Hasumi M; Suzuki K; Matsui H; Koike H; Ito K; Yamanaka H
Cancer Lett; 2003 Oct; 200(2):187-95. PubMed ID: 14568174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
